Kira Gordon and Matt Majewski recently authored an article in MedTech Strategist discussing how hospital consolidation is increasing purchasing leverage through greater pricing transparency and that has substantiated a need for new pricing models in medtech. There are challenges associated with several emerging pricing models; regardless, manufacturers will need to develop innovative approaches to maximize opportunity while minimizing risk.
Webinar Insights | The Rise of Competitive Rare Diseases: European Payer Perspectives
CRA recently hosted a webinar with leading European payer experts to discuss the increasingly competitive rare disease (RD) landscape